CarePayment Technologies (OTCMKTS:CPYT) & Co-Diagnostics (NASDAQ:CODX) Head to Head Survey

CarePayment Technologies (OTCMKTS:CPYT) and Co-Diagnostics (NASDAQ:CODX) are both medical companies, but which is the superior business? We will contrast the two companies based on the strength of their risk, dividends, profitability, valuation, institutional ownership, earnings and analyst recommendations.

Valuation & Earnings

This table compares CarePayment Technologies and Co-Diagnostics”s top-line revenue, earnings per share (EPS) and valuation.

	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
CarePayment Technologies	N/A	N/A	N/A	N/A	N/A
Co-Diagnostics	$507,892.00	32.38	-$37.64 million	($0.99)	-0.27

CarePayment Technologies has higher earnings, but lower revenue than Co-Diagnostics.

Analyst Ratings

This is a summary of recent ratings and recommmendations for CarePayment Technologies and Co-Diagnostics, as provided by MarketBeat.

	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
CarePayment Technologies	0	0	0	0	0.00
Co-Diagnostics	1	2	1	1	2.40

Co-Diagnostics has a consensus price target of $1.83, indicating a potential upside of 578.76%. Given Co-Diagnostics’ stronger consensus rating and higher probable upside, analysts plainly believe Co-Diagnostics is more favorable than CarePayment Technologies.

Profitability

This table compares CarePayment Technologies and Co-Diagnostics’ net margins, return on equity and return on assets.

	Net Margins	Return on Equity	Return on Assets
CarePayment Technologies	N/A	N/A	N/A
Co-Diagnostics	-6,347.34%	-70.26%	-61.19%

Institutional and Insider Ownership

15.0% of Co-Diagnostics shares are owned by institutional investors. 13.9% of CarePayment Technologies shares are owned by insiders. Comparatively, 5.4% of Co-Diagnostics shares are owned by insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a stock will outperform the market over the long term.

Summary

Co-Diagnostics beats CarePayment Technologies on 6 of the 10 factors compared between the two stocks.

About CarePayment Technologies

CarePayment Technologies, Inc. provides accounts receivable services in the United States. It offers services for accounts receivables generated by healthcare providers in connection with providing healthcare services to their patients under the CarePayment brand name. The company was formerly known as microHelix, Inc. CarePayment Technologies, Inc. was founded in 1991 and is based in Lake Oswego, Oregon.

About Co-Diagnostics

Co-Diagnostics, Inc., a molecular diagnostics company, develops, manufactures, and sells reagents used for diagnostic tests that function through the detection and/or analysis of nucleic acid molecules in the United States and internationally. The company offers Co-Dx PCR platform, a polymerase chain reaction (PCR) testing to patients in point-of-care and at-home setting. It also provides PCR diagnostic tests for COVID-19, influenza, tuberculosis, hepatitis B and C, human papillomavirus, malaria, chikungunya, dengue, and the zika virus. In addition, the company offers three multiplexed tests to test mosquitos for the identification of diseases carried by the mosquitos; molecular tools for detection of infectious diseases, liquid biopsy for cancer screening, and agricultural applications; tests that identify genetic traits in plant and animal genomes; and portable diagnostic device designed to bring PCR to patients in point-of-care and at-home settings. The company was incorporated in 2013 and is headquartered in Salt Lake City, Utah.